From the lab into the clinic – Meet us at DGHO 2026 in Vienna!
From 9–12 October 2026, the hematology and oncology community will meet in Vienna for scientific exchange and networking. Precision medicine and personalized treatment will be high on the agenda.
This year, BIOTYPE's focus is on acute myeloid leukemia. Molecular genetic insights support decisions throughout the AML patient journey, from diagnosis to monitoring.
Arrange a meeting with Marie Helbig at DGHO 2026 to discuss BIOTYPE's solutions for leukemia diagnostics and more. We look forward to seeing you there!















_ESMO-2025-Save-the-Date%20-%20website.jpg)





_DGHO-2025-Save-the-Date---web.jpg)
_Brennpunkt-Urologie-2025-Save-the-Date---Web.jpg)































